Acurx Pharmaceuticals, Inc.
ACXP
$0.4791
-$0.0872-15.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.64M | 3.71M | 5.76M | 6.36M | 8.92M |
| Total Receivables | -- | 51.10K | 97.40K | 51.10K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 161.60K | 100.10K | 122.80K | 168.40K | 187.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.81M | 3.86M | 5.98M | 6.58M | 9.11M |
|
|
|||||
| Total Current Assets | 4.81M | 3.86M | 5.98M | 6.58M | 9.11M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.81M | 3.86M | 5.98M | 6.58M | 9.11M |
|
|
|||||
| Total Accounts Payable | 3.40K | 4.80K | 19.10K | 10.10K | 9.20K |
| Total Accrued Expenses | 2.49M | 3.24M | 3.30M | 3.14M | 3.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.49M | 3.24M | 3.32M | 3.15M | 3.11M |
|
|
|||||
| Total Current Liabilities | 2.49M | 3.24M | 3.32M | 3.15M | 3.11M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.49M | 3.24M | 3.32M | 3.15M | 3.11M |
|
|
|||||
| Common Stock & APIC | 71.78M | 67.94M | 67.20M | 65.15M | 63.60M |
| Retained Earnings | -69.47M | -67.32M | -64.54M | -61.72M | -57.60M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.31M | 615.10K | 2.66M | 3.43M | 6.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.31M | 615.10K | 2.66M | 3.43M | 6.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.31M | 615.10K | 2.66M | 3.43M | 6.00M |
|
|
|||||